Literature DB >> 7476818

Status epilepticus.

C W Chang1, T P Bleck.   

Abstract

Status epilepticus is defined as a condition characterized by epileptic seizure prolonged or repeated so as to produce a lasting epileptic state. It is estimated that status epilepticus occurs in 50,000 to 60,000 individuals in the United States, with one third to one half of episodes occurring in patients with established epilepsy.

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7476818

Source DB:  PubMed          Journal:  Neurol Clin        ISSN： 0733-8619            Impact factor:   3.806


  5 in total

1.  Efficacy of levetiracetam versus fosphenytoin for the recurrence of seizures after status epilepticus.

Authors:  Kensuke Nakamura; Ryota Inokuchi; Hiroaki Daidoji; Hiromu Naraba; Tomohiro Sonoo; Hideki Hashimoto; Kurato Tokunaga; Takahiro Hiruma; Kent Doi; Naoto Morimura
Journal:  Medicine (Baltimore)       Date:  2017-06       Impact factor: 1.889

2.  Levetiracetam vs. Fosphenytoin for Second-Line Treatment of Status Epilepticus: Propensity Score Matching Analysis Using a Nationwide Inpatient Database.

Authors:  Kensuke Nakamura; Hiroyuki Ohbe; Hiroki Matsui; Yuji Takahashi; Aiki Marushima; Yoshiaki Inoue; Kiyohide Fushimi; Hideo Yasunaga
Journal:  Front Neurol       Date:  2020-07-02       Impact factor: 4.003

3.  Changes in Real-world Practice Patterns of Antiepileptic Drugs for Status Epilepticus: A Nationwide Observational Study in Japan.

Authors:  Kensuke Nakamura; Hiroyuki Ohbe; Hiroki Matsui; Yuji Takahashi; Aiki Marushima; Yoshiaki Inoue; Kiyohide Fushimi; Hideo Yasunaga
Journal:  Neurol Med Chir (Tokyo)       Date:  2020-01-31       Impact factor: 1.742

4.  Levetiracetam versus fosphenytoin as a second-line treatment after diazepam for status epilepticus: study protocol for a multicenter non-inferiority designed randomized control trial.

Authors:  Kensuke Nakamura; Aiki Marushima; Yuji Takahashi; Akio Kimura; Masahiro Asami; Satoshi Egawa; Junya Kaneko; Yutaka Kondo; Chikara Yonekawa; Eisei Hoshiyama; Takeshi Yamada; Kazushi Maruo; Yoshiaki Inoue
Journal:  Trials       Date:  2021-05-02       Impact factor: 2.728

Review 5.  Super-Refractory Status Epilepticus: Prognosis and Recent Advances in Management.

Authors:  Batool F Kirmani; Katherine Au; Lena Ayari; Marita John; Padmashri Shetty; Robert J Delorenzo
Journal:  Aging Dis       Date:  2021-07-01       Impact factor: 6.745
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.